Cancer Genetics Aktie
WKN DE: A1W4HC / ISIN: US13739U1043
26.03.2014 21:24:48
|
Cancer Genetics Q4 Loss Narrows - Quick Facts
(RTTNews) - Cancer Genetics, Inc. (CGIX) posted fourth-quarter net loss of $2.5 million or $0.37 per share, narrower than $4.0 million or $3.86 per share in the comparable quarter last year.
Revenue for the latest fourth quarter rose to $1.85 million from $1.08 million in the prior year period.
On average, two analysts polled by Thomson Reuters expected the company to report a loss of $0.36 per share on revenue of $1.95 million. Analysts' estimates typically exclude special items.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cancer Genetics Incmehr Nachrichten
Keine Nachrichten verfügbar. |